Prot #MN42988: A Phase IV Multicenter, Open-label Study Evaluating B Cell Levels in Infants Potentially Exposed to Ocrelizumab During Pregnancy - the Minore Study

Project: Research project

Project Details

StatusActive
Effective start/end date3/30/223/30/25

Funding

  • PPD Investigator Services, LLC (Prot #MN42988 // Prot #MN42988)
  • Genentech, Inc (Prot #MN42988 // Prot #MN42988)